Supplementary Files
Keywords
Amlodipine
Delayed reaction
Lymphocyte transformation test
Abstract
Background: Amlodipine is one of the third generation dihydropyridine calcium channel blockers used for hypertension. Mild, moderate and severe reactions have been reported with calcium channel blockers. Cross-reactivity among these drugs has not been established.
Case report: We have presented the case of a patient who developed a delayed pruritic, and erythematous maculopapular skin exanthema after the intake of amlodipine. A positive lymphocyte transformation test (LTT) confirmed the implication of amlodipine in the reaction and showed positivity to another calcium channel blocker, nifedipine, demonstrating cross reactivity.
Conclusion: This is the first reported case of hypersensitivity to amlodipine in which the involvement of the drug is confirmed by a positive TTL. TTL could become a good diagnostic alternative for patients who experience late reactions to amlodipine and possibly cross-reactivity with nifedipine.References
Fares H, DiNicolantonio JJ, O'Keefe JH, Lavie CJ. Amlodipine in hypertension: A first-line agent with efficacy for improving blood pressure and patient outcomes. Open Heart. 2016;3(2):e000473. DOI: http://dx.doi.org/10.1136/openhrt-2016-000473
Southward J, Irvine E, Rabinovich M. Probable amlodipine-induced angioedema. Ann Pharmacother. 2009;43(4):772-776. DOI: http://dx.doi.org/10.1345/aph.1L527
Baetz BE, Patton ML, Guiday RE, Reigart CL, Ackerman BH. Amlodipine-induced toxic epidermal necrolysis. J Burn Care Res. 2011;32(5):158-160. DOI: http://dx.doi.org/10.1097/BCR.0b013e31822ac7be
Park KY, Kim BJ, Kim MN. Amlodipine-associated bullous pemphigoid with erythema multiforme-like clinical features. Int J Dermatol. 2011;50:637-639. DOI: http://dx.doi.org/10.1111/j.1365-4632.2009.04417.x
Wiwanitkit S, Wiwanitkit V. Oral mucositis, Steven Johnson syndrome and amlodipine usage in a case with metabolic syndrome. Diabetes Metab Syndr. 2012;6(2):112. DOI: http://dx.doi.org/10.1016/j.dsx.2012.08.016
Gonzalo-Garijo MA, Pérez-Calderón R, De-Argila-Fernández-Durán D, Rangel-Mayoral JF. Cutaneous reactions due to diltiazem and cross reactivity with other calcium channel blockers. Allergol Immunopathol (Madr). 2005;33(4):238-240. Disponible en: https://pdfs.semanticscholar.org/c51a/1213bf42340b2603d5d93f16a977793f889a.pdf
Pichler WJ, editor. Drug hypersensitivity. Suiza: Karger; 2007.
Ariza A, Montañez MI, Fernández TD Perkins JR, Mayorga C. Cellular tests for the evaluation of drug hypersensitivity. Curr Pharm Des. 2016;22(45): 6773-6783. DOI: http://dx.doi.org/10.2174/1381612822666161107165917
Dominguez-Ortega J, Entrala A, Pola-Bibian B, Gonzalez-Muñoz M, Fiandor A, Quirce S. Delayed allergic reaction to acenocoumarol with a positive lymphocyte transformation test. J Investig Allergol Clin Immunol. 2016;26(4):273-275. DOI: http://dx.doi.org/10.18176/jiaci.0072
González-Cavero L, Domínguez-Ortega J, González-Muñoz M, Mayor-Ibarguren A, Tomás M, Fiandor A, et al. Delayed allergic reaction to terbinafine with a positive lymphocyte transformation test. J Invest Allergol Clin Immunol. 2017;27(2):136-137. DOI: http://dx.doi.org/10.18176/jiaci.0133
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2017 Revista Alergia México